Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.
Pol Arch Intern Med. 2020 Jun 03;:
Authors: Sierpiński R, Pinkas J, Jankowski M, Zgliczyński WS, Wierzba W, Gujski M, Szumowski Ł
INTRODUCTION: The Coronavirus Disease 2019 (COVID 19) is a communicable disease caused by novel coronavirus.
OBJECTIVES: This study aimed to assess self-reported frequency of gastrointestinal symptoms and olfactory or taste disorders in non-hospitalized patients with COVID-19 in Poland.
PATIENTS AND METHODS: This cross-sectional survey was conducted between April 17 and 18, 2020, among 4,516 non-hospitalized patients with COVID-19 in Poland. The questionnaire included eight questions related to the health status, symptoms of COVID-19, comorbidities, and smoking status.
RESULTS: Completed questionnaires were obtained from 1,942 patients with COVID-19, a response rate of 43%. The median age of the respondents was 50 years; 60.2% were women. Among non-hospitalized patients with COVID-19, 21.3% had hypertension, 4.5% had diabetes, and 3.1% of COVID-19 cases had chronic respiratory disease. Regular tobacco use was declared by 11.2% of patients with COVID-19. At least one gastrointestinal symptom was reported by 53.6% of patients. Almost half of patients (47%) with COVID-19 reported lack of appetite and 24.2% reported diarrhea. Among 1,942 interviewed patients, 54.2% reported at least one olfactory or taste disorder and 42.5% reported both alterations. Self-reported olfactory and taste disorders were 49.2% and 47.5%, respectively. Self-reported frequency of gastrointestinal symptoms and olfactory or taste disorders during COVID-19 course was significantly higher (p<0.001) among women than men.
CONCLUSIONS: In conclusion, this study demonstrated that olfactory and taste disorders are frequent symptoms in mild-to-moderate COVID-19 patients. Moreover, our study indicates gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among non-hospitalized patients with COVID-19.
PMID: 32491298 [PubMed - as supplied by publisher]